IDA Total Non-Current Liabilities

IDACORP, Inc. Common Stock · Total Non-Current Liabilities

IDA logo

IDA Total Non-Current Liabilities

Latest reported$6.13B
IDA Quarterly Total Non-Current Liabilities ($1.13B → $6.13B)
High-resolution chart · PNG

IDA total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

IDACORP, Inc. Common Stock Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
6,126,081,000
6,074,266,000
5,748,916,000
5,702,175,000
5,786,671,000
5,565,192,000
5,200,607,000
5,221,361,000
4,947,594,000
4,919,621,000
4,927,099,000
4,875,740,000
4,509,375,000
4,515,965,000
4,180,078,000
4,262,954,000
4,289,286,000
4,272,749,000
4,209,657,000
4,233,913,000
4,257,210,000
4,240,568,000
4,241,217,000
4,054,967,000
4,071,396,000
3,888,825,000
3,795,789,000
3,741,128,000
3,755,820,000
3,728,711,000
3,748,351,000
3,664,753,000
3,669,906,000
3,667,975,000
3,588,542,000
3,889,229,000
3,899,758,000
3,886,151,000
3,882,316,000
3,771,156,000
3,763,067,000
3,757,163,000
3,718,964,000
3,678,521,000
3,660,799,000
3,666,031,000
3,517,507,000
3,305,185,000
3,267,707,000
3,253,121,000
3,259,451,000
3,392,077,000
3,367,245,000
3,281,035,000
3,205,247,000
3,165,136,000
3,109,977,000
3,032,181,000
2,930,668,000
2,911,586,000
2,735,838,000
2,705,330,000
2,691,012,000
2,670,675,000
2,507,972,000
2,487,267,000
2,618,954,000
2,437,551,000
2,421,552,000
2,396,213,000
2,324,700,000
2,194,100,000
2,071,900,000
2,078,100,000
2,070,700,000
2,020,000,000
2,014,400,000
1,861,500,000
1,910,600,000
1,971,700,000
2,015,500,000
2,033,200,000
2,045,300,000
2,000,400,000
1,942,100,000
1,948,800,000
1,940,400,000
1,928,000,000
1,927,800,000
1,960,000,000
1,877,800,000
1,721,200,000
1,720,100,000
1,691,300,000
1,885,700,000
1,630,000,000
1,571,000,000
1,626,000,000
1,760,000,000
1,796,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.